These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 12692801

  • 1. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
    Hempel L, Misselwitz J, Fleck C, Kentouche K, Leder C, Appenroth D, Rost M, Zintl F.
    Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of renal function after high-dose methotrexate treatment in children.
    Grönroos MH, Jahnukainen T, Möttönen M, Perkkiö M, Irjala K, Salmi TT.
    Pediatr Blood Cancer; 2008 Oct; 51(4):535-9. PubMed ID: 18523995
    [Abstract] [Full Text] [Related]

  • 3. Effective removal of methotrexate by high-flux hemodialysis.
    Saland JM, Leavey PJ, Bash RO, Hansch E, Arbus GS, Quigley R.
    Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of low dose methotrexate in rheumatoid arthritis.
    Seideman P, Müller-Suur R, Ekman E.
    J Rheumatol; 1993 Jul; 20(7):1126-8. PubMed ID: 8371203
    [Abstract] [Full Text] [Related]

  • 5. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS, Mamoudou AD, Tuckuviene R, Wehner PS, Schroeder H.
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [Abstract] [Full Text] [Related]

  • 6. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.
    Cancer; 2004 Apr 15; 100(8):1724-33. PubMed ID: 15073863
    [Abstract] [Full Text] [Related]

  • 7. Low prevalence of high-dose methotrexate nephropathy in patients with malignancy.
    Mashhadi MA, Kaykhaei MA, Sanadgol H.
    Iran J Kidney Dis; 2012 Mar 15; 6(2):105-9. PubMed ID: 22388607
    [Abstract] [Full Text] [Related]

  • 8. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC.
    Cancer; 2004 May 15; 100(10):2222-32. PubMed ID: 15139068
    [Abstract] [Full Text] [Related]

  • 9. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H, Kihira K, Kuwata N, Arai S, Kimura Y, Miyake K, Kitaura T, Fujimura K, Kuramoto A, Fukuchi H.
    Hiroshima J Med Sci; 1996 Jun 15; 45(2):57-62. PubMed ID: 8810132
    [Abstract] [Full Text] [Related]

  • 10. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC.
    J Clin Oncol; 2006 Aug 20; 24(24):3858-64. PubMed ID: 16921038
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A, Mühlisch J, Frühwald MC, Gerss J, Hempel G, Boos J.
    Ther Drug Monit; 2010 Aug 20; 32(4):467-75. PubMed ID: 20571463
    [Abstract] [Full Text] [Related]

  • 12. Renal dysfunctions secondary to ifosfamide treatment in children.
    Tokuc G, Yalçiner A, Kebudi R, Dogan S, Görgün O, Ayan I.
    J Exp Clin Cancer Res; 1997 Jun 20; 16(2):227-30. PubMed ID: 9261752
    [Abstract] [Full Text] [Related]

  • 13. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial.
    Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J.
    Bone Marrow Transplant; 2001 Feb 20; 27(3):319-27. PubMed ID: 11277181
    [Abstract] [Full Text] [Related]

  • 14. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA, Martínez Colmenero C, Peláez Pleguezuelos I, Leiva Gea I, López García AB, de la Cruz Moreno J.
    An Pediatr (Barc); 2009 Sep 20; 71(3):230-4. PubMed ID: 19617010
    [Abstract] [Full Text] [Related]

  • 15. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
    Schwartz S, Borner K, Müller K, Martus P, Fischer L, Korfel A, Auton T, Thiel E.
    Oncologist; 2007 Nov 20; 12(11):1299-308. PubMed ID: 18055849
    [Abstract] [Full Text] [Related]

  • 16. Urinary N-acetyl-beta-D-glucosaminidase activity in leukaemic children during high-dose methotrexate therapy.
    Oláh VA, Békési A, Tóth A, Kovács I, Balla G.
    Haematologia (Budap); 1995 Nov 20; 26(3):151-7. PubMed ID: 7797145
    [Abstract] [Full Text] [Related]

  • 17. Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia.
    Ylinen E, Jahnukainen K, Saarinen-Pihkala UM, Jahnukainen T.
    Pediatr Blood Cancer; 2014 Dec 20; 61(12):2199-202. PubMed ID: 25174822
    [Abstract] [Full Text] [Related]

  • 18. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
    Xu WQ, Tang YM, Fang CQ, Song H, Shi SW, Yang SL, Ren DT, Shen HQ, Qian BQ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 20; 26(1):15-8. PubMed ID: 15946502
    [Abstract] [Full Text] [Related]

  • 19. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
    Lin XB, Zhou NN, Li S, Cai QQ, Xia ZJ, Liao H, Gao Y, Huang HQ.
    Ai Zheng; 2008 Oct 20; 27(10):1100-5. PubMed ID: 18851792
    [Abstract] [Full Text] [Related]

  • 20. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H, Morita T, Hirata Y, Kato T, Okada Y, Sato T.
    Gan To Kagaku Ryoho; 2000 Mar 20; 27(3):475-8. PubMed ID: 10740644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.